HLA-DRB1 and Absence of circulating granulocytes: Chen et al.28 reported that HLA-DRB1*08:03 was associated with increased risk of drug-induced agranulocytosis in patients with Graves’ disease (OR, 4.36, P = 1.8 × 10−9) in Taiwanese.